199 related articles for article (PubMed ID: 24164366)
1. [Ultra high risk chronic lymphocytic leukemia - characteristics and treatment options].
Lysák D; Jindra P
Vnitr Lek; 2013 Oct; 59(10):887-94. PubMed ID: 24164366
[TBL] [Abstract][Full Text] [Related]
2. [Chronic lymphocytic leukemia : treatment concepts in transition].
Eichhorst B; Hallek M
Internist (Berl); 2015 Apr; 56(4):374-80. PubMed ID: 25776793
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Sorror ML; Maris MB; Sandmaier BM; Storer BE; Stuart MJ; Hegenbart U; Agura E; Chauncey TR; Leis J; Pulsipher M; McSweeney P; Radich JP; Bredeson C; Bruno B; Langston A; Loken MR; Al-Ali H; Blume KG; Storb R; Maloney DG
J Clin Oncol; 2005 Jun; 23(16):3819-29. PubMed ID: 15809448
[TBL] [Abstract][Full Text] [Related]
4. [News in therapeutic management of chronic lymphoid leukemia].
Michallet AS; Salles G; Coiffier B; Michallet M
Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919
[TBL] [Abstract][Full Text] [Related]
5. Key issues in the treatment of chronic lymphocytic leukaemia (CLL).
Catovsky D; Murphy RL
Eur J Cancer; 1995 Dec; 31A(13-14):2146-54. PubMed ID: 8652233
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
Motta M; Wierda WG; Ferrajoli A
Cancer; 2009 Sep; 115(17):3830-41. PubMed ID: 19536902
[TBL] [Abstract][Full Text] [Related]
7. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
8. Understanding and managing ultra high-risk chronic lymphocytic leukemia.
Stilgenbauer S; Zenz T
Hematology Am Soc Hematol Educ Program; 2010; 2010():481-8. PubMed ID: 21239840
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation.
Khouri IF; Keating MJ; Saliba RM; Champlin RE
Cytotherapy; 2002; 4(3):217-21. PubMed ID: 12194718
[TBL] [Abstract][Full Text] [Related]
10. The treatment of relapsed refractory chronic lymphocytic leukemia.
Brown JR
Hematology Am Soc Hematol Educ Program; 2011; 2011():110-8. PubMed ID: 22160021
[TBL] [Abstract][Full Text] [Related]
11. Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?
Dreger P; Montserrat E; ;
Curr Hematol Malig Rep; 2015 Mar; 10(1):59-64. PubMed ID: 25651976
[TBL] [Abstract][Full Text] [Related]
12. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
[TBL] [Abstract][Full Text] [Related]
13. Pitting new treatments for chronic lymphocytic leukemia against old ones: how do they fare?
Shvidel L; Berrebi A
Expert Rev Hematol; 2016 Mar; 9(3):245-54. PubMed ID: 26613391
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
[TBL] [Abstract][Full Text] [Related]
15. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on chronic lymphocytic leukemia: a Pharma Matters report.
D'Souza P; Walker G
Drugs Today (Barc); 2014 Jul; 50(7):485-501. PubMed ID: 25101331
[TBL] [Abstract][Full Text] [Related]
17. [Chronic lymphocytic leukemia: update on pathophysiology and management].
Suzumiya J
Rinsho Ketsueki; 2018; 59(5):511-520. PubMed ID: 29877241
[TBL] [Abstract][Full Text] [Related]
18. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Perkins JG; Flynn JM; Howard RS; Byrd JC
Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
[TBL] [Abstract][Full Text] [Related]
19. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia: diagnosis and treatment.
Yee KW; O'Brien SM
Mayo Clin Proc; 2006 Aug; 81(8):1105-29. PubMed ID: 16901035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
